Full name
PHARMAX APTEKI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 0,2 | -0 | -120,2 |
EBITDA | 0,2 | -0,1 | -128,2 |
Short time liabilities | 0,2 | 0,1 | -42,4 |
Equity capital | 1,2 | 1 | -18,4 |
Operating profit (EBIT) | 0,2 | -0,1 | -128,2 |
Assets | 1,4 | 1,1 | -21,5 |
Net profit (loss) | 0,2 | -0 | -121,5 |
Cash | 0,5 | 0,4 | -16 |
Liabilities and provisions for liabilities | 0,2 | 0,1 | -42,4 |
Net income from sale | 6,1 | 4,6 | -25,2 |
Working assets | 1,4 | 1,1 | -21,5 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 15,1 | -4 | -19,1 |
Equity capital to total assets | 87 | 90,5 | 3,5 |
Gross profit margin | 3 | -0,8 | -3,8 |
EBITDA Margin | 3 | -1,1 | -4,1 |
Days | Days | Days | |
Short term commitment turnover cycle | 11 | 8 | -3 |
Current financial liquidity indicator | 7.687148094177246 | 10.479181289672852 | 2,8 |
Net dept to EBITDA | -2.7799088954925537 | 8.27824592590332 | 11,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane